Polycystic Ovary Syndrome and BETATROPHIN
NCT04448730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73
Last updated 2020-06-26
Summary
This is an original study giving an information about the association body mass index, polycystic ovary syndrome and betatrophin.
Conditions
- Polycystic Ovary
- Obesity
Interventions
- DIAGNOSTIC_TEST
-
serum marker levels
two groups comparisons
Sponsors & Collaborators
-
Hatice Akkaya
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2019-07-30
- Completion
- 2019-12-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
NCT05418595 ·Status: COMPLETED
-
The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
NCT05929950 ·Status: UNKNOWN
-
Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome Phenotypes
NCT06164132 ·Status: COMPLETED
-
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
NCT05843955 ·Status: COMPLETED
-
Short Term Ketogenic Diet in Polycictic Ovary Syndrome
NCT06469255 ·Status: COMPLETED ·Phase: NA
-
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894 ·Status: COMPLETED
-
Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.
NCT01162447 ·Status: UNKNOWN
-
Adipose Expression of Leptin, Adiponectin and IL-6 and Plasma Levels of Adipocytokines in Women With and Without Polycystic Ovary Syndrome (PCOS)
NCT01088061 ·Status: COMPLETED
-
Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary Patients
NCT05830487 ·Status: UNKNOWN ·Phase: NA
-
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
NCT07146815 ·Status: COMPLETED ·Phase: NA
-
Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
NCT07027332 ·Status: COMPLETED
-
Serum Endocan Levels in Polycystic Ovary Syndrome
NCT03019679 ·Status: COMPLETED
-
Breast Ultrasonography and Polycystic Ovary Syndrome
NCT04231786 ·Status: COMPLETED
-
Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,
NCT03765905 ·Status: COMPLETED
-
Visceral Adiposity Index Differences Between Subtypes of Polycystic Ovary Syndrome
NCT06358300 ·Status: COMPLETED
-
Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity
NCT01382576 ·Status: COMPLETED
-
The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study
NCT05734287 ·Status: RECRUITING
-
Lifestyle Change in Women With Polycystic Ovary Syndrome
NCT05377021 ·Status: COMPLETED ·Phase: NA
-
Novel Subtypes of Polycystic Ovary Syndrome
NCT06124391 ·Status: RECRUITING
-
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
NCT03587415 ·Status: COMPLETED
-
Clusterin Level and Polycystic Ovary Syndrome
NCT06601725 ·Status: COMPLETED
-
Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome
NCT04776915 ·Status: UNKNOWN
-
High Versus Normal Protein Diet in Polycystic Ovary Syndrome (PCOS)
NCT01184963 ·Status: COMPLETED ·Phase: NA
-
Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism
NCT06371313 ·Status: COMPLETED
-
The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
NCT01475019 ·Status: UNKNOWN ·Phase: PHASE4